The pre-screening form should be administered to all adult patients.
It rules out patients who are at low or no-risk using one pre-screening question for alcohol and one pre-screening question for drugs.
The Alcohol Use Disorders Identification Test (AUDIT) should be administered to adult patients who screen positive on the pre-screening for alcohol use.
Side one contains the screening questions and side two contains instructions on scoring and interpreting the AUDIT.
The Drug Abuse Screen Test (DAST-10) was designed to provide a brief, self-report instrument for population screening, clinical case finding and treatment evaluation research. It can be used with adults and older youth.
The DAST-10 yields a quantitative index of the degree of consequences related to drug use. The instrument takes approximately 5 minutes to administer and may be given in either a self-report or interview format. The DAST-10 may be used in a variety of settings to provide a quick index of patient/client drug use issues.
The DAST-10 is a 10-item self-report instrument that has been condensed from the 28-item DAST. It was copyrighted in 1982 by Harvey Skinner, PhD and the Centre for Addiction and Mental Health, Toronto, Canada. To request permission to use the tool, please contact Dr. Harvey Skinner at hskinner@yorku.ca
The CRAFFT questions are copyright protected by Boston Children’s Hospital; however, a goal of CABHRe is to make the CRAFFT widely available to qualified clinicians and researchers, and we welcome reproductions of this screening tool.
To learn more about conditions for using the CRAFFT screen in your work, refer to: https://crafft.org/get-the-crafft/
This screening tool is intended for use with patients ages 9 to 18 and screens only for alcohol use.
The Brief Screener for Alcohol, Tobacco, and other Drugs (BSTAD) tool consists of frequency of use questions to identify risky substance use by adolescent patients ages 12-17. The accompanying resources assist clinicians in providing patient feedback and resources for follow-up.
The Screening to Brief Intervention (S2BI) tool consists of frequency of use questions to categorize substance use by adolescent patients ages 12-17 into different risk categories. The accompanying resources assist clinicians in providing patient feedback and resources for follow-up.